Tramadol
Regulatory milestones approvals, filings & regulatory actions · 4 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | TRAMADOL HYDROCHLORIDE | — | 2011-09-20 | fda.gov ↗ |
| Label expansions (2) | US (FDA) | ULTRAM | — | 1998-08-21 – 1999-12-23 | fda.gov ↗ |
| Approved | US (FDA) | ULTRAM | — | 1995-03-03 | fda.gov ↗ |
Trials 173 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 03 trials | ||||||
| Phase 0 | NCT06561672 | Sep 2024 → Mar 2025 overdue | — | Zagazig University | Enrolling by invitation | No outcome recorded |
| Phase 0 | NCT05756504 | Feb 2023 → Jan 2024 | acute pancreatitis | Hayatabad Medical Complex | Unknown | No outcome recorded |
| Phase 0 | NCT05614440 | May 2012 → Nov 2013 | — | Marmara University | Completed | No outcome recorded |
| Phase 121 trials | ||||||
| Phase 1 | NCT07060209 | Sep → Oct 2025 overdue | — | Haiphong University of Medicine and Pharmacy | Recruiting | No outcome recorded |
| Phase 1 | NCT07032558 | Sep 2025 overdue | — | Haiphong University of Medicine and Pharmacy | Recruiting | No outcome recorded |
| Phase 1 | NCT05925686 | Jun → Oct 2023 | — | Parc de Salut Mar | Completed | No outcome recorded |
| Phase 1 | NCT04375865 | May → Jul 2020 | — | Addpharma Inc. | Completed | No outcome recorded |
| Phase 1 | NCT03767036 | Jun 2017 | — | Grünenthal GmbH | Completed | No outcome recorded |
| Phase 1 | NCT03766984 | Jun 2015 | — | Grünenthal GmbH | Completed | No outcome recorded |
| Phase 1 | NCT02307864 | Dec 2014 → Aug 2015 | — | Janssen Scientific Affairs, LLC | Completed | No outcome recorded |
| Phase 1 | NCT01947920 | Aug → Nov 2013 | — | Janssen Scientific Affairs, LLC | Completed | No outcome recorded |
| Phase 1 | NCT01606059 | May → Jun 2012 | — | Daewon Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT01880125 | Jan → May 2012 | — | Yungjin Pharm. Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT01800682 | Jul → Sep 2011 | — | Janssen Research & Development, LLC | Completed | No outcome recorded |
| Phase 1 | NCT00772967 | Jun → Nov 2008 | osteoarthritis | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 1 | NCT00973232 | May → Aug 2008 | — | Labopharm Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01586507 | Oct 2007 → Sep 2008 | — | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
| Phase 1 | NCT01586494 | Oct 2007 → Jun 2009 | — | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
| Phase 1 | NCT00487175 | Sep → Dec 2007 | — | University Hospital, Clermont-Ferrand | Completed | No outcome recorded |
| Phase 1 | NCT00834912 | Feb → Apr 2006 | — | Labopharm Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00834366 | Feb → Mar 2005 | — | Labopharm Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00911742 | Feb → Mar 2004 | — | Labopharm Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00834808 | Nov → Dec 2002 | — | Labopharm Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00653315 | May → Aug 2002 | — | Par Pharmaceutical, Inc. | Completed | No outcome recorded |
| Phase 1/26 trials | ||||||
| Phase 1/2 | NCT04454307 | Jul → Aug 2020 | COVID-19 | Tanta University | Unknown | No outcome recorded |
| Phase 1/2 | NCT03121547 | May 2015 → Jan 2016 | drug-induced dyskinesia | Frederiksberg University Hospital | Completed | No outcome recorded |
| Phase 1/2 | NCT01188421 | Oct 2010 → Jun 2015 | opiate dependence | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1/2 | NCT01178203 | Jul 2010 | pulpitis | Azad University of Medical Sciences | Completed | No outcome recorded |
| Phase 1/2 | NCT00301210 | Jan 2006 → Oct 2007 | substance-related disorder | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1/2 | NCT00111046 | Feb 2001 → Feb 2004 | malignant choroid melanoma | Royal Liverpool University Hospital | Unknown | No outcome recorded |
| Phase 215 trials | ||||||
| Phase 2 | NCT06345716 | Apr 2024 → Mar 2025 overdue | urinary tract obstruction | University of Monastir | Recruiting | No outcome recorded |
| Phase 2 | NCT05616364 | Mar 2023 → Mar 2024 | benign shuddering attacks | Sana Bahadur | Unknown | No outcome recorded |
| Phase 2 | NCT04752384 | Jul 2021 → Apr 2024 | head and neck squamous cell carcinoma | Medical College of Wisconsin | Completed | No outcome recorded |
| Phase 2 | NCT05463367 | Jan 2021 → Jun 2025 overdue | chronic pain syndrome, opiate dependence, substance abuse | Northwestern University | Active not recruiting | No outcome recorded |
| Phase 2 | NCT03850587 | Aug 2018 → May 2020 | osteoarthritis, knee | Yooyoung Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT02999594 | Dec 2016 → Apr 2018 | — | Maulana Azad Medical College | Unknown | No outcome recorded |
| Phase 2 | NCT02014363 | Oct 2013 → Oct 2015 | major depressive disorder | e-Therapeutics PLC | Completed | No outcome recorded |
| Phase 2 | NCT02247648 | Jun 2013 → Dec 2017 | — | University of Montreal Hospital Centre (CHUM) | Terminated | No outcome recorded |
| Phase 2 | NCT01552096 | Dec 2011 → Oct 2013 | inflammatory disease | Imam Abdulrahman Bin Faisal University | Completed | No outcome recorded |
| Phase 2 | NCT01307020 | Feb → Oct 2011 | — | Menarini Group | Completed | No outcome recorded |
| Phase 2 | NCT01630343 | Jan 2010 → Apr 2012 | — | Queen Elizabeth Hospital, Hong Kong | Completed | No outcome recorded |
| Phase 2 | NCT00752661 | Jun → Nov 2007 | osteoarthritis | Janssen Pharmaceutical K.K. | Completed | No outcome recorded |
| Phase 2 | NCT00952068 | Jan → Apr 2007 | — | Labopharm Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00333346 | Sep 2006 → Apr 2009 | — | University Hospital, Ghent | Completed | No outcome recorded |
| Phase 2 | NCT00142896 | Feb → Dec 2005 | opiate dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT06735443 | Mar 2021 → Apr 2022 | hernia, double inguinal | Sahiwal medical college sahiwal | Completed | No outcome recorded |
| Phase 2/3 | NCT00980044 | Oct 2009 → Feb 2012 | substance withdrawal syndrome | Michelle Lofwall | Completed | No outcome recorded |
| Phase 338 trials | ||||||
| Phase 3 | NCT05928520 | Aug 2023 → Sep 2024 | — | Al-Azhar University | Unknown | No outcome recorded |
| Phase 3 | NCT07469826 | Oct 2022 → Apr 2023 | — | Jinnah Postgraduate Medical Centre | Completed | No outcome recorded |
| Phase 3 | NCT05324059 | Jul 2022 → Apr 2023 | neuropathy, painful | Laboratorios Silanes S.A. de C.V. | Completed | No outcome recorded |
| Phase 3 | NCT07043049 | Jun → Dec 2022 | benign shuddering attacks | Syed Muhammad Abbas | Completed | No outcome recorded |
| Phase 3 | NCT05390905 | Jun → Dec 2022 | — | Haisco Pharmaceutical Group Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT05311722 | Apr → Dec 2022 | — | Sheikh Zayed Medical College | Unknown | No outcome recorded |
| Phase 3 | NCT05362851 | Nov 2021 → Jan 2023 | osteoarthritis, knee | Yooyoung Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
| Phase 3 | NCT04312061 | Mar → Jul 2020 | — | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT03678792 | Nov 2019 → Sep 2020 | opiate dependence, substance withdrawal syndrome | University of Alabama at Birmingham | Withdrawn | No outcome recorded |
| Phase 3 | NCT03586934 | Jun 2018 → Jun 2019 | substance-related disorder | Rush University Medical Center | Withdrawn | No outcome recorded |
| Phase 3 | NCT03395808 | Dec 2017 → Apr 2019 | — | Avenue Therapeutics, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT03714672 | Aug 2017 → Mar 2018 | — | Grünenthal GmbH | Completed | No outcome recorded |
| Phase 3 | NCT03062644 | Apr 2017 → Jun 2018 | — | Mundipharma Research GmbH & Co KG | Completed | No outcome recorded |
| Phase 3 | NCT01904149 | May 2013 → May 2014 | — | Menarini Group | Completed | No outcome recorded |
| Phase 3 | NCT01902134 | Apr 2013 → Feb 2014 | — | Menarini Group | Completed | No outcome recorded |
| Phase 3 | NCT02658721 | Jan → Jun 2013 | — | Bagcilar Training and Research Hospital | Completed | No outcome recorded |
| Phase 3 | NCT01889979 | Oct 2012 → May 2013 | — | Saint Thomas Hospital, Panama | Completed | No outcome recorded |
| Phase 3 | NCT00983736 | Oct 2009 → Sep 2010 | premature ejaculation | Bausch Health Americas, Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT01476774 | Aug 2009 → Jun 2010 | intervertebral disk degenerative disorder | Mundipharma (China) Pharmaceutical Co. Ltd | Completed | No outcome recorded |
| Phase 3 | NCT00983151 | Aug 2009 → Sep 2010 | premature ejaculation | Bausch Health Americas, Inc. | Terminated | No outcome recorded |
| Phase 3 | NCT01112267 | May → Oct 2009 | — | Janssen Korea, Ltd., Korea | Completed | No outcome recorded |
| Phase 3 | NCT03365817 | Feb 2009 → Dec 2014 | chronic pain syndrome, substance-related disorder | Rigshospitalet, Denmark | Completed | No outcome recorded |
| Phase 3 | NCT00736853 | Jun 2008 → Jan 2009 | — | Janssen Pharmaceutical K.K. | Completed | No outcome recorded |
| Phase 3 | NCT00736957 | May 2008 → Oct 2009 | chronic pain syndrome | Janssen Pharmaceutical K.K. | Completed | No outcome recorded |
| Phase 3 | NCT00737048 | Mar → Sep 2008 | — | Janssen Pharmaceutical K.K. | Completed | No outcome recorded |
| Phase 3 | NCT00713726 | Jan 2006 → Jul 2008 | — | Federal University of São Paulo | Completed | No outcome recorded |
| Phase 3 | NCT00833794 | Oct 2004 → Jan 2006 | osteoarthritis | Labopharm Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00236535 | Dec 2003 → Oct 2004 | — | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
| Phase 3 | NCT00210847 | Dec 2003 → May 2005 | diabetic polyneuropathy | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
| Phase 3 | NCT00833911 | Apr 2003 → Jul 2004 | osteoarthritis, knee | Labopharm Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00832416 | Jan → Aug 2003 | osteoarthritis, knee | Labopharm Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00852917 | Jan → Aug 2003 | — | Labopharm Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00348452 | Sep 2002 → Aug 2003 | chronic pain syndrome | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00912015 | Mar 2002 → Jul 2003 | osteoarthritis, knee | Labopharm Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00325858 | Jan 2002 → Dec 2003 | chronic pain syndrome | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00347724 | Nov 2000 → Nov 2001 | chronic pain syndrome | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00348010 | Nov 2000 → Jul 2001 | chronic pain syndrome | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00347685 | Oct 2000 → Feb 2003 | chronic pain syndrome | Bausch Health Americas, Inc. | Completed | No outcome recorded |
| Phase 459 trials | ||||||
| Phase 4 | NCT07064993 | Jul 2026 → Feb 2027 expected | — | Arzu Esen Tekeli | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07440069 | Feb → Aug 2026 overdue | — | Universidad Nacional Autonoma de Honduras | Recruiting | No outcome recorded |
| Phase 4 | NCT07113782 | Nov 2024 → Apr 2025 | benign prostatic hyperplasia | Armed Forces Institute of Urology, Rawalpindi | Completed | No outcome recorded |
| Phase 4 | NCT06612996 | Oct 2024 → Jan 2025 overdue | ulcer of lower limbs, varicose disease | Al-Azhar University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06495632 | Aug 2024 → Jul 2026 overdue | — | Cape Fear Valley Health System | Recruiting | No outcome recorded |
| Phase 4 | NCT06076707 | Nov 2023 → May 2024 | — | Wollo University | Unknown | No outcome recorded |
| Phase 4 | NCT06113497 | Nov 2023 → Oct 2024 | — | Kyunghee University Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT05825560 | May 2023 → Jun 2026 | — | Nîmes University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05657704 | Oct 2022 → Dec 2023 | — | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Unknown | No outcome recorded |
| Phase 4 | NCT06231043 | Apr 2022 → Mar 2023 | — | Lampang Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05237492 | Jan 2022 → Jul 2023 | blood coagulation disease, platelet disorder, undefined, poisoning | Medical University of Graz | Completed | No outcome recorded |
| Phase 4 | NCT05183334 | Dec 2021 → Dec 2022 | premature ejaculation | Assiut University | Unknown | No outcome recorded |
| Phase 4 | NCT04991493 | Sep 2021 → Nov 2023 | — | Affiliated Cancer Hospital of Shantou University Medical College | Unknown | No outcome recorded |
| Phase 4 | NCT05488925 | Jun 2021 → Feb 2022 | pulpitis | Farjad Zafar | Completed | No outcome recorded |
| Phase 4 | NCT04551833 | Apr 2021 → Apr 2023 | — | Assiut University | Unknown | No outcome recorded |
| Phase 4 | NCT04391855 | May 2020 → Nov 2022 | neuropathy, painful, spinal cord disorder, spinal stenosis | Aristotle University Of Thessaloniki | Completed | No outcome recorded |
| Phase 4 | NCT03809442 | Jun 2019 → Aug 2023 | — | Aga Khan University | Completed | No outcome recorded |
| Phase 4 | NCT04835116 | Apr → Oct 2019 | — | Armed Forces Institute of Urology, Rawalpindi | Completed | No outcome recorded |
| Phase 4 | NCT03781544 | Jan 2019 → Jul 2025 | osteoarthritis | University of Zurich | Unknown | No outcome recorded |
| Phase 4 | NCT03694873 | Oct → Dec 2018 | — | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT03509740 | Apr → Oct 2018 | primary dysmenorrhea | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT03469310 | Mar 2018 → Dec 2019 | goiter, parathyroid gland adenoma, parathyroid hyperplasia, thyroid cancer | Minerva A Romero Arenas | Completed | No outcome recorded |
| Phase 4 | NCT03477851 | Jun 2017 → Jun 2020 | bone disorder | Medical University of Warsaw | Completed | No outcome recorded |
| Phase 4 | NCT03622489 | Mar 2017 → Aug 2018 | — | Wolfson Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT02958566 | Jan → Dec 2017 | colon carcinoma, constipation disorder, diverticulitis of colon, paralytic ileus +1 | University of Illinois College of Medicine at Peoria | Unknown | No outcome recorded |
| Phase 4 | NCT02777970 | Apr 2016 → Feb 2017 | — | Menarini Group | Completed | No outcome recorded |
| Phase 4 | NCT02964416 | Mar 2016 → Mar 2018 | brain neoplasm | Aga Khan University | Completed | No outcome recorded |
| Phase 4 | NCT02851394 | Oct 2015 → May 2016 | — | Centre Hospitalier Universitaire Dijon | Completed | No outcome recorded |
| Phase 4 | NCT02595190 | Mar 2015 → Mar 2020 | pain agnosia | Southwest Hospital, China | Unknown | No outcome recorded |
| Phase 4 | NCT02110966 | Apr → Oct 2014 | pulpitis | Daniel Chavarría Bolaños | Completed | No outcome recorded |
| Phase 4 | NCT01916915 | Jul 2013 → Feb 2016 | neuropathy, painful | Ufuk University | Completed | No outcome recorded |
| Phase 4 | NCT01943760 | Sep 2012 → Sep 2013 | — | Federal University of São Paulo | Completed | No outcome recorded |
| Phase 4 | NCT01517711 | Sep 2011 → Aug 2014 | post-traumatic stress disorder | INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium | Completed | No outcome recorded |
| Phase 4 | NCT01416116 | Jul 2011 → Apr 2012 | peripheral nerve lesion, postherpetic neuralgia | Astellas Pharma Inc | Completed | No outcome recorded |
| Phase 4 | NCT01782846 | Mar 2011 → Feb 2013 | — | Hopital Foch | Completed | No outcome recorded |
| Phase 4 | NCT01345162 | Mar 2010 → May 2012 | — | Fondazione IRCCS Policlinico San Matteo di Pavia | Completed | No outcome recorded |
| Phase 4 | NCT00766675 | Oct 2008 → Mar 2009 | fibromyalgia | Johnson & Johnson Taiwan Ltd | Completed | No outcome recorded |
| Phase 4 | NCT00766402 | Sep 2008 → Feb 2009 | ankylosing spondylitis | Johnson & Johnson Taiwan Ltd | Terminated | No outcome recorded |
| Phase 4 | NCT00785603 | Aug 2008 | depressive disorder | University of Southern Denmark | Unknown | No outcome recorded |
| Phase 4 | NCT02246712 | Jun 2008 → May 2010 | neuropathy, painful, type 1 diabetes mellitus, type 2 diabetes mellitus | São Paulo State University | Completed | No outcome recorded |
| Phase 4 | NCT00735748 | Mar 2008 → Jun 2009 | — | University Hospital, Ghent | Completed | No outcome recorded |
| Phase 4 | NCT01019265 | Mar 2008 → Mar 2009 | osteoarthritis | Mundipharma Korea Ltd | Completed | No outcome recorded |
| Phase 4 | NCT00647517 | Mar 2008 → Jul 2009 | ankylosing spondylitis | Chung Shan Medical University | Completed | No outcome recorded |
| Phase 4 | NCT00560443 | Feb 2008 → Apr 2012 | — | IRCCS Burlo Garofolo | Completed | No outcome recorded |
| Phase 4 | NCT00692263 | Feb → Aug 2008 | — | University of Southern Denmark | Completed | No outcome recorded |
| Phase 4 | NCT01728246 | Oct 2007 → May 2008 | osteoarthritis | Janssen Pharmaceutica | Completed | No outcome recorded |
| Phase 4 | NCT01843660 | Sep 2007 → May 2008 | — | Xian-Janssen Pharmaceutical Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT00635349 | May 2007 → Apr 2009 | osteoarthritis | Janssen Korea, Ltd., Korea | Completed | No outcome recorded |
| Phase 4 | NCT00519246 | Feb → Dec 2007 | neuropathy, painful | Nanjing Medical University | Completed | No outcome recorded |
| Phase 4 | NCT00510666 | Jan → May 2007 | — | Nanjing Medical University | Completed | No outcome recorded |
| Phase 4 | NCT00634543 | Dec 2006 → Oct 2008 | diabetic neuropathy | Janssen Korea, Ltd., Korea | Completed | No outcome recorded |
| Phase 4 | NCT00310908 | Sep 2006 → Feb 2009 | nephrolithiasis | Hadassah Medical Organization | Completed | No outcome recorded |
| Phase 4 | NCT00290901 | Mar → Dec 2006 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 4 | NCT00576173 | Dec 2005 → Feb 2007 | — | Johnson & Johnson Taiwan Ltd | Completed | No outcome recorded |
| Phase 4 | NCT01063842 | Aug 2005 → May 2006 | osteoarthritis | Janssen Korea, Ltd., Korea | Completed | No outcome recorded |
| Phase 4 | NCT00210561 | Mar → Apr 2005 | — | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Terminated | No outcome recorded |
| Phase 4 | NCT00297375 | Apr → Aug 2003 | migraine disorder | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
| Phase 4 | NCT00236483 | Nov 2002 → Feb 2003 | — | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
| Phase 4 | NCT00246168 | ? → Jun 2005 | rheumatoid arthritis | Janssen Korea, Ltd., Korea | Completed | No outcome recorded |
| Phase not applicable29 trials | ||||||
| — | NCT07610408 | Jun → Sep 2026 expected | — | Ankara Etlik City Hospital | Recruiting | No outcome recorded |
| — | NCT06860100 | Nov 2025 → Jun 2026 overdue | hemorrhoid | Yuzuncu Yil University | Active not recruiting | No outcome recorded |
| — | NCT07264309 | Nov 2025 → Dec 2026 expected | — | Zohar Nachum | Recruiting | No outcome recorded |
| — | NCT07036237 | Mar → Nov 2025 overdue | — | Dow University of Health Sciences | Enrolling by invitation | No outcome recorded |
| — | NCT07386288 | Nov 2024 → Apr 2025 | — | Ataturk University | Completed | No outcome recorded |
| — | NCT06240390 | May → Aug 2024 | neuropathy, painful | Universidad Europea de Canarias | Withdrawn | No outcome recorded |
| — | NCT06608056 | Jan → Jun 2024 | — | Pakistan Air Force (PAF) Hospital Islamabad | Completed | No outcome recorded |
| — | NCT06112223 | Apr → Sep 2023 | — | Tanta University | Completed | No outcome recorded |
| — | NCT05538052 | Apr → Nov 2022 | pulpitis | Jamia Millia Islamia | Completed | No outcome recorded |
| — | NCT05311774 | Apr 2022 → Oct 2025 | — | Assiut University | Completed | No outcome recorded |
| — | NCT05905757 | Mar 2022 → Mar 2023 | — | Yuzuncu Yil University | Completed | No outcome recorded |
| — | NCT06642480 | Jan 2022 → Mar 2023 | — | National Research and Innovation Agency | Completed | No outcome recorded |
| — | NCT03532841 | May → Aug 2018 | — | Cairo University | Unknown | No outcome recorded |
| — | NCT04176783 | Mar 2018 → Jul 2021 | — | OrthoCarolina Research Institute, Inc. | Completed | No outcome recorded |
| — | NCT03934411 | Mar 2018 → Mar 2019 | substance-related disorder | University of Copenhagen | Completed | No outcome recorded |
| — | NCT04037878 | Nov 2017 → Jun 2020 | — | Aga Khan University | Completed | No outcome recorded |
| — | NCT03054220 | Jul 2016 → Dec 2018 | — | Jules Desmeules | Completed | No outcome recorded |
| — | NCT03693222 | May → Nov 2016 | — | Bakirkoy Dr. Dr. Sadi Konuk Research and Training Hospital | Completed | No outcome recorded |
| — | NCT02971540 | Feb 2016 → Jul 2017 | lumbar disk disease | Medical University of Silesia | Completed | No outcome recorded |
| — | NCT02440399 | Jul 2015 → May 2017 | — | HaEmek Medical Center, Israel | Completed | No outcome recorded |
| — | NCT03260439 | Jun → Dec 2014 | — | Leila mansali stambouli | Completed | No outcome recorded |
| — | NCT02012244 | Jan → Dec 2014 | colorectal cancer | Severance Hospital | Completed | No outcome recorded |
| — | NCT02750696 | Apr 2013 → Dec 2014 | suppurative periapical periodontitis | Federal University of Rio Grande do Sul | Completed | No outcome recorded |
| — | NCT01764048 | Nov 2012 → Jan 2014 | — | HaEmek Medical Center, Israel | Completed | No outcome recorded |
| — | NCT01227200 | Nov 2011 | peritonsillar abscess | HaEmek Medical Center, Israel | Unknown | No outcome recorded |
| — | NCT05831761 | Sep 2009 → Oct 2011 | — | University Medical Centre Ljubljana | Completed | No outcome recorded |
| — | NCT00610155 | Sep 2008 → Jul 2010 | — | Viatris Inc. | Completed | No outcome recorded |
| — | NCT00386243 | Dec 2007 → May 2012 | chronic pain syndrome | VA Office of Research and Development | Completed | No outcome recorded |
| — | NCT00361686 | Jan 2006 → Jan 2007 | — | Rabin Medical Center | Completed | No outcome recorded |
Also used as a comparator or background therapy in 218 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT07204379 Comparator | Jan → Jul 2023 | — | Armed Forces Institute of Dentistry, Pakistan | Completed | No outcome recorded |
| Phase 112 trials | ||||||
| Phase 1 | NCT05256108 Comparator | Mar → Jul 2022 | substance abuse | Tris Pharma, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT05533073 Comparator | Aug → Sep 2020 | — | Laboratorios Silanes S.A. de C.V. | Completed | No outcome recorded |
| Phase 1 | NCT05389150 Comparator | Jan → Feb 2019 | — | Laboratorios Silanes S.A. de C.V. | Completed | No outcome recorded |
| Phase 1 | NCT03775629 Comparator | Dec 2018 → Apr 2019 | — | CrystalGenomics, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT03640247 Background | Nov 2018 → Dec 2019 | parathyroid gland disorder, thyroid gland disorder | MetroHealth Medical Center | Completed | No outcome recorded |
| Phase 1 | NCT04330547 Comparator | Feb 2018 → Feb 2019 | akinetic mutism, brain injury | University of Liege | Completed | No outcome recorded |
| Phase 1 | NCT03312777 Comparator | Oct → Dec 2017 | — | Syntrix Biosystems, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02205554 Comparator | Aug → Oct 2014 | — | Syntrix Biosystems, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01776515 Comparator | Jan → Mar 2012 | — | Daewon Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT00743587 Comparator | Sep 2008 → Mar 2009 | osteoarthritis, hand | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT02329561 Comparator | Jan → Feb 2007 | — | University of Montreal | Completed | No outcome recorded |
| Phase 1 | NCT00834288 Comparator | Jun → Aug 2003 | — | Labopharm Inc. | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT06780267 Comparator | Mar 2025 → Mar 2026 | — | Shandong Suncadia Medicine Co., Ltd. | Completed | No outcome recorded |
| Phase 1/2 | NCT00499746 Comparator | Nov 2007 → Apr 2010 | opiate dependence, opioid abuse | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 218 trials | ||||||
| Phase 2 | NCT05125978 Comparator | Sep 2026 → Jul 2028 | chronic pain syndrome | EMS | Withdrawn | No outcome recorded |
| Phase 2 | NCT06232577 Background | Mar 2024 → May 2027 expected | — | M.D. Anderson Cancer Center | Active not recruiting | No outcome recorded |
| Phase 2 | NCT06334198 Comparator | Mar 2024 → Mar 2025 | opioid-induced constipation | Asbjørn Mohr Drewes | Unknown | No outcome recorded |
| Phase 2 | NCT04593329 Comparator | Mar → Aug 2023 | — | EMS | Withdrawn | No outcome recorded |
| Phase 2 | NCT06385561 Comparator | Aug 2022 → May 2023 | opioid-induced constipation | Asbjørn Mohr Drewes | Completed | No outcome recorded |
| Phase 2 | NCT05470075 Comparator | Aug → Dec 2022 | — | Jiangsu HengRui Medicine Co., Ltd. | Terminated | No outcome recorded |
| Phase 2 | NCT05995912 Comparator | Sep 2021 → Aug 2022 | — | Laboratorios Liomont | Completed | No outcome recorded |
| Phase 2 | NCT04178109 Comparator | Jan → Nov 2019 | — | KAT General Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02441673 Comparator | Oct 2018 → Jan 2019 | benign shuddering attacks | Lagos State Health Service Commission | Unknown | No outcome recorded |
| Phase 2 | NCT03383315 Background | Jul → Sep 2017 | poisoning | University of Malaya | Completed | No outcome recorded |
| Phase 2 | NCT02839668 Background | Aug 2016 → Sep 2019 | breast cancer | Iuliu Hatieganu University of Medicine and Pharmacy | Completed | No outcome recorded |
| Phase 2 | NCT02845271 Background | Jul 2016 → Jun 2017 | osteoarthritis | Genzyme, a Sanofi Company | Completed | No outcome recorded |
| Phase 2 | NCT02703415 Comparator | Jun 2016 → Aug 2017 | — | Assiut University | Completed | No outcome recorded |
| Phase 2 | NCT02307305 Background | Aug 2014 → Dec 2016 | neuropathy, painful | Hanyang University Seoul Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT02068209 Comparator | May 2014 → Mar 2015 | pain agnosia | Cairo University | Completed | No outcome recorded |
| Phase 2 | NCT02071303 Comparator | May → Nov 2014 | — | Cairo University | Completed | No outcome recorded |
| Phase 2 | NCT02182752 Comparator | Apr 2013 → Jan 2016 | rotator cuff syndrome | Asklepieion Voulas General Hospital | Completed | No outcome recorded |
| Phase 2 | NCT00497562 Background | May 2004 → Nov 2005 | fibromyalgia, pituitary deficiency | Centro Medico Teknon | Completed | No outcome recorded |
| Phase 2/310 trials | ||||||
| Phase 2/3 | NCT07185594 Comparator | Oct → Dec 2025 overdue | — | Shandong Suncadia Medicine Co., Ltd. | Recruiting | No outcome recorded |
| Phase 2/3 | NCT07098962 Comparator | Aug → Dec 2025 | — | Kastamonu University | Completed | No outcome recorded |
| Phase 2/3 | NCT05982392 Comparator | Mar → Aug 2023 | pulpitis | Dow University of Health Sciences | Completed | No outcome recorded |
| Phase 2/3 | NCT04939987 Comparator | Aug → Oct 2022 | — | Wake Forest University Health Sciences | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT04813016 Comparator | Mar 2021 → Apr 2022 | — | National Cancer Institute, Egypt | Completed | No outcome recorded |
| Phase 2/3 | NCT04589494 Comparator | Apr 2020 → Feb 2021 | chronic pain syndrome | Assiut University | Unknown | No outcome recorded |
| Phase 2/3 | NCT03496389 Comparator | Jul 2018 → Jul 2019 | — | Hospital Authority, Hong Kong | Unknown | No outcome recorded |
| Phase 2/3 | NCT03380533 Comparator | Sep 2016 → Dec 2017 | rotator cuff syndrome | Hospital Italiano de Buenos Aires | Completed | No outcome recorded |
| Phase 2/3 | NCT02617199 Comparator | Nov 2015 → Dec 2016 | acute pancreatitis | Hospital General Naval de Alta Especialidad - Escuela Medico Naval | Unknown | No outcome recorded |
| Phase 2/3 | NCT02449954 Comparator | Jun 2014 → Apr 2015 | breast cancer | Assiut University | Unknown | No outcome recorded |
| Phase 333 trials | ||||||
| Phase 3 | NCT06237231 Comparator | Feb → Mar 2025 overdue | — | EMS | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07666178 Comparator | Dec 2024 → Dec 2027 expected | — | Instituto do Coracao | Recruiting | No outcome recorded |
| Phase 3 | NCT06722742 Comparator | Sep → Dec 2024 overdue | — | Liaquat National Hospital & Medical College | Recruiting | No outcome recorded |
| Phase 3 | NCT06561035 Background | Sep 2024 → Aug 2025 overdue | — | Campbell Clinic | Enrolling by invitation | No outcome recorded |
| Phase 3 | NCT06274333 Comparator | Feb 2024 → Aug 2026 overdue | nephrolithiasis | Al-Azhar University | Recruiting | No outcome recorded |
| Phase 3 | NCT06215820 Comparator | Dec 2023 → Aug 2024 | — | Viatris Specialty LLC | Completed | No outcome recorded |
| Phase 3 | NCT06215859 Comparator | Dec 2023 → Jan 2025 | — | Viatris Specialty LLC | Completed | No outcome recorded |
| Phase 3 | NCT04647435 Comparator | May 2023 → Oct 2024 | — | Apsen Farmaceutica S.A. | Completed | No outcome recorded |
| Phase 3 | NCT04968158 Comparator | Nov 2021 → Mar 2022 | — | Laboratorios Silanes S.A. de C.V. | Completed | No outcome recorded |
| Phase 3 | NCT04613830 Comparator | Nov 2020 → Nov 2022 | childhood malignant neoplasm | Assiut University | Completed | No outcome recorded |
| Phase 3 | NCT03774836 Comparator | Dec 2018 → May 2019 overdue | — | Avenue Therapeutics, Inc. | Active not recruiting | No outcome recorded |
| Phase 3 | NCT02722603 Comparator | Sep 2018 → May 2019 | chronic pain syndrome | Pharmaceutical Research Management srl | Terminated | No outcome recorded |
| Phase 3 | NCT03585036 Comparator | Jul → Sep 2018 | — | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT03255330 Comparator | Oct 2017 → Feb 2020 | spinal cord injury | Masaryk University | Withdrawn | No outcome recorded |
| Phase 3 | NCT03290378 Comparator | Sep 2017 → Apr 2018 | — | Avenue Therapeutics, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT03108482 Comparator | Mar → Nov 2017 | — | Esteve Pharmaceuticals, S.A. | Completed | No outcome recorded |
| Phase 3 | NCT03324035 Background | Mar 2017 → May 2021 | leprosy, neuropathy, painful, peripheral neuropathy | University of Sao Paulo | Unknown | No outcome recorded |
| Phase 3 | NCT02982161 Comparator | Dec 2016 → Jan 2018 | — | Mundipharma Research GmbH & Co KG | Completed | No outcome recorded |
| Phase 3 | NCT02736071 Comparator | Jun 2016 → Apr 2017 | — | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT02736019 Comparator | Jun 2016 → Apr 2017 | — | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT02760888 Comparator | May → Jun 2016 | — | Ain Shams University | Unknown | No outcome recorded |
| Phase 3 | NCT02528253 Comparator | Aug 2015 → Oct 2017 | — | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT02419651 Comparator | Apr 2015 → Dec 2017 | — | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT02428777 Comparator | Apr 2015 → Dec 2019 | — | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT02425709 Comparator | Apr 2015 → Dec 2017 | — | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT02465255 Comparator | Mar 2015 → Jun 2017 | — | IRCCS Burlo Garofolo | Completed | No outcome recorded |
| Phase 3 | NCT01952314 Comparator | May 2014 → Aug 2015 | ureterolithiasis | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT01721031 Comparator | Apr 2013 → Dec 2015 | — | West China Hospital | Completed | No outcome recorded |
| Phase 3 | NCT01598753 Comparator | May 2012 → Jul 2018 | fibromyalgia | University of Washington | Completed | No outcome recorded |
| Phase 3 | NCT01814878 Comparator | Nov 2009 → Jan 2011 | neuropathy, painful | Janssen Korea, Ltd., Korea | Completed | No outcome recorded |
| Phase 3 | NCT00643383 Comparator | Mar 2008 → Jan 2009 | — | Labopharm Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00662558 Comparator | Jan → Sep 2008 | — | Viatris Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00950651 Comparator | Mar → Nov 2002 | osteoarthritis, knee | Labopharm Inc. | Completed | No outcome recorded |
| Phase 462 trials | ||||||
| Phase 4 | NCT07600697 Comparator | Jul 2026 → Jul 2027 expected | female stress incontinence, pelvic organ prolapse | University of California, Los Angeles | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07153003 Comparator | Feb 2026 → Sep 2030 expected | — | Mayo Clinic | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT07066111 Comparator | Jul 2025 → Dec 2026 expected | delirium | Nanjing First Hospital, Nanjing Medical University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07332572 Comparator | Jun → Dec 2025 | — | Liaquat National Hospital & Medical College | Completed | No outcome recorded |
| Phase 4 | NCT06742554 Comparator | Dec 2024 → Apr 2025 overdue | — | medina medical center | Active not recruiting | No outcome recorded |
| Phase 4 | NCT06113211 Background | Oct 2024 → Sep 2026 expected | disease of bone structure, substance-related disorder | Henry Ford Health System | Recruiting | No outcome recorded |
| Phase 4 | NCT06373978 Comparator | Aug 2024 → Jun 2026 overdue | chronic pain syndrome | The Cleveland Clinic | Recruiting | No outcome recorded |
| Phase 4 | NCT07315022 Comparator | Aug 2024 → Aug 2025 | — | First Affiliated Hospital, Sun Yat-Sen University | Completed | No outcome recorded |
| Phase 4 | NCT06172920 Comparator | Dec 2023 → Nov 2024 | respiratory system disorder | Baskent University | Unknown | No outcome recorded |
| Phase 4 | NCT06134895 Comparator | Aug → Nov 2023 | benign shuddering attacks | Ziauddin University | Unknown | No outcome recorded |
| Phase 4 | NCT05820685 Background | Jul 2023 → Apr 2024 | nervous system injury | The University of Texas Health Science Center, Houston | Terminated | No outcome recorded |
| Phase 4 | NCT06269770 Comparator | May 2023 → May 2025 | chronic pain syndrome | University of Thessaly | Unknown | No outcome recorded |
| Phase 4 | NCT06601530 Background | Aug → Sep 2022 | coronary artery disorder | Istanbul University - Cerrahpasa | Completed | No outcome recorded |
| Phase 4 | NCT05488847 Background | Jun 2022 → Dec 2024 overdue | arthropathy | Henry Ford Health System | Active not recruiting | No outcome recorded |
| Phase 4 | NCT05144828 Background | Feb 2022 → Oct 2024 | lung disorder, neuropathy, painful | Medical College of Wisconsin | Completed | No outcome recorded |
| Phase 4 | NCT05172739 Comparator | Oct 2021 → Nov 2025 overdue | chronic pain syndrome, non-small cell lung carcinoma, substance-related disorder | University of Crete | Recruiting | No outcome recorded |
| Phase 4 | NCT05500677 Comparator | Jun → Nov 2021 | — | Ankara City Hospital Bilkent | Completed | No outcome recorded |
| Phase 4 | NCT04766996 Background | May → Dec 2021 | substance-related disorder | Emory University | Terminated | No outcome recorded |
| Phase 4 | NCT04837924 Background | Apr 2021 → May 2022 | — | General Hospital Sveti Duh | Completed | No outcome recorded |
| Phase 4 | NCT04694300 Background | Feb 2021 → Aug 2022 | — | Hersh, Elliot V., DMD, MS, PhD | Completed | No outcome recorded |
| Phase 4 | NCT05956275 Comparator | Dec 2020 → Oct 2021 | — | Siirt Training and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04894864 Comparator | Oct 2020 → Sep 2026 expected | abdominal aortic aneurysm | University of Crete | Recruiting | No outcome recorded |
| Phase 4 | NCT05170841 Comparator | Sep 2020 → May 2022 | — | Menarini International Operations Luxembourg SA | Completed | No outcome recorded |
| Phase 4 | NCT04457986 Comparator | Jul → Sep 2020 | lumbar disk disease | Diskapi Teaching and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03534895 Background | May 2019 → May 2020 | neuropathy, painful | University of Porto | Unknown | No outcome recorded |
| Phase 4 | NCT04521556 Comparator | Apr 2019 → Apr 2021 | — | University Hospital of Split | Completed | No outcome recorded |
| Phase 4 | NCT04587505 Comparator | Apr 2019 → Apr 2021 | — | University Hospital of Split | Completed | No outcome recorded |
| Phase 4 | NCT03701984 Comparator | Oct 2018 → Aug 2019 | — | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT03472469 Comparator | Apr 2018 → Jul 2019 | — | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase 4 | NCT03454217 Comparator | Mar 2018 → Sep 2020 | sleep apnea syndrome | Centre Hospitalier Universitaire Vaudois | Completed | No outcome recorded |
| Phase 4 | NCT03309163 Comparator | Oct 2017 → Jun 2019 | — | Xinqiao Hospital of Chongqing | Completed | No outcome recorded |
| Phase 4 | NCT04110665 Comparator | Sep 2017 → Sep 2019 | disease of the tendon | Nîmes University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03067103 Comparator | Jul 2017 | neuropathy, painful, sleep apnea syndrome | Federal University of Goiás | Unknown | No outcome recorded |
| Phase 4 | NCT03126084 Comparator | May → Nov 2017 | — | Bozyaka Training and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02827487 Comparator | Jul 2016 → Jul 2020 | — | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT02706509 Comparator | Mar 2016 → Sep 2017 | — | Meir Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT02484859 Comparator | Jul → Dec 2015 | nasal cavity polyp | Recep Tayyip Erdogan University | Completed | No outcome recorded |
| Phase 4 | NCT02416141 Comparator | Apr → Nov 2015 | infertility disorder | University Hospital Brussels | Unknown | No outcome recorded |
| Phase 4 | NCT02361567 Comparator | Apr 2015 → Mar 2016 | — | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| Phase 4 | NCT02327923 Comparator | Jan 2015 → Feb 2016 | gallstones | B.P. Koirala Institute of Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT02416804 Comparator | Jan 2015 → Jul 2016 | spinal stenosis | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02445599 Background | Apr 2014 → Apr 2016 | lung disorder | University of Debrecen | Completed | No outcome recorded |
| Phase 4 | NCT02544282 Comparator | Apr 2014 → Mar 2016 | — | GZA Ziekenhuizen Campus Sint-Augustinus | Completed | No outcome recorded |
| Phase 4 | NCT02076893 Comparator | Mar 2014 → Feb 2017 | — | Children's Hospitals and Clinics of Minnesota | Terminated | No outcome recorded |
| Phase 4 | NCT01887951 Comparator | Feb → Aug 2014 | — | Singapore General Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01983111 Comparator | Oct 2013 → Nov 2014 | — | Mundipharma Korea Ltd | Completed | No outcome recorded |
| Phase 4 | NCT02035904 Background | Jan 2013 → Sep 2017 | chronic pain syndrome | Fondazione IRCCS Policlinico San Matteo di Pavia | Unknown | No outcome recorded |
| Phase 4 | NCT02248493 Background | Nov 2012 → Mar 2017 | neuropathy, painful | Lithuanian University of Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT02518438 Comparator | May 2012 → Mar 2013 | — | Yeditepe University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02412930 Comparator | Mar 2012 → Mar 2016 | — | Cukurova University | Completed | No outcome recorded |
| Phase 4 | NCT01558622 Comparator | Mar → May 2012 | — | Kavaklıdere Umut Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02291705 Comparator | Jan 2012 → Nov 2014 | — | Cukurova University | Completed | No outcome recorded |
| Phase 4 | NCT02850211 Comparator | Sep 2011 → Nov 2015 | rotator cuff syndrome | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02389361 Comparator | Apr → Sep 2011 | — | Astes | Completed | No outcome recorded |
| Phase 4 | NCT01267136 Comparator | Jan 2011 → May 2012 | tonsillitis | Children's Hospitals and Clinics of Minnesota | Completed | No outcome recorded |
| Phase 4 | NCT01116531 Comparator | Apr 2010 → Dec 2012 | diabetic polyneuropathy, postherpetic neuralgia | Turku University Hospital | Withdrawn | No outcome recorded |
| Phase 4 | NCT01526525 Comparator | Jul 2009 → Sep 2011 | neuropathy, painful | G.Gennimatas General Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02436980 Comparator | Jan → Sep 2009 | — | Karadeniz Technical University | Completed | No outcome recorded |
| Phase 4 | NCT00893412 Comparator | Nov 2008 → Apr 2009 | infertility disorder | University Hospital Brussels | Completed | No outcome recorded |
| Phase 4 | NCT00733421 Comparator | Oct 2008 → Jun 2009 | — | Karolinska Institutet | Completed | No outcome recorded |
| Phase 4 | NCT00942565 Comparator | Apr 2007 → Oct 2008 | — | The University of Hong Kong | Completed | No outcome recorded |
| Phase 4 | NCT00426647 Comparator | Feb 2007 → Jul 2009 | osteoarthritis | Norpharma A/S | Completed | No outcome recorded |
| Phase not applicable80 trials | ||||||
| — | NCT07672808 Background | Jun → Dec 2026 expected | osteoarthritis, hip | Henry Ford Health System | Not yet recruiting | No outcome recorded |
| — | NCT07534488 Comparator | Apr → Jun 2026 overdue | pilonidal sinus | Medipol University | Not yet recruiting | No outcome recorded |
| — | NCT07606638 Comparator | Feb → Jul 2026 overdue | oral cavity squamous cell carcinoma | Mayo Hospital Lahore | Enrolling by invitation | No outcome recorded |
| — | NCT07294352 Comparator | Jan → Jul 2026 overdue | — | CMH Lahore Medical College and Institute of Dentistry | Active not recruiting | No outcome recorded |
| — | NCT07346872 Comparator | Dec 2025 → Aug 2026 overdue | — | Bursa Yuksek Ihtisas Training and Research Hospital | Active not recruiting | No outcome recorded |
| — | NCT07241949 Comparator | Dec 2025 → Nov 2026 expected | — | Cukurova University | Recruiting | No outcome recorded |
| — | NCT07096765 Background | Aug 2025 → Jan 2026 overdue | — | Bursa Yuksek Ihtisas Training and Research Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06344403 Background | Jun 2025 → Oct 2026 expected | herpes zoster | Beijing Tiantan Hospital | Active not recruiting | No outcome recorded |
| — | NCT07110051 Comparator | Jan → Sep 2025 overdue | childhood malignant neoplasm | National Cancer Institute, Egypt | Recruiting | No outcome recorded |
| — | NCT06728033 Comparator | Jan 2025 → May 2027 expected | bone disorder | West China Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06656299 Background | Oct 2024 → Nov 2025 overdue | acute cholecystitis, cholelithiasis | Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital | Recruiting | No outcome recorded |
| — | NCT06015165 Comparator | Sep 2024 → Jun 2025 overdue | — | China-Japan Friendship Hospital | Recruiting | No outcome recorded |
| — | NCT05840406 Background | Sep 2024 → Mar 2025 | — | University Hospital Sestre Milosrdnice | Completed | No outcome recorded |
| — | NCT07500454 Comparator | Jun → Jul 2024 | — | ISSSTE Hospital Regional "Gral. Ignacio Zaragoza" | Completed | No outcome recorded |
| — | NCT07057934 Background | Apr → Jun 2024 | cholelithiasis | Dr. Lutfi Kirdar Kartal Training and Research Hospital | Completed | No outcome recorded |
| — | NCT06326281 Comparator | Mar → Sep 2024 | — | Ankara City Hospital Bilkent | Unknown | No outcome recorded |
| — | NCT07604376 Background | Mar 2024 → Jul 2026 overdue | — | Matild Keresztes | Recruiting | No outcome recorded |
| — | NCT06112548 Background | Mar 2024 → Nov 2025 | osteoarthritis, knee | Damascus University | Completed | No outcome recorded |
| — | NCT07139691 Comparator | Jan 2024 → Jul 2026 overdue | — | Matild Keresztes | Active not recruiting | No outcome recorded |
| — | NCT07568938 Comparator | Jan 2024 → Feb 2027 expected | obesity disorder, substance-related disorder | G.Gennimatas General Hospital | Recruiting | No outcome recorded |
| — | NCT07337135 Background | Oct 2023 → Apr 2024 | morbid obesity | Hospital dos Lusíadas | Completed | No outcome recorded |
| — | NCT06008002 Comparator | Aug → Dec 2023 | gallbladder disorder | Bursa Yuksek Ihtisas Training and Research Hospital | Completed | No outcome recorded |
| — | NCT05621161 Comparator | Nov 2022 → Aug 2023 | osteoarthritis, knee | Mursel Ekinci | Completed | No outcome recorded |
| — | NCT05630404 Comparator | Nov 2022 → Aug 2023 | lumbar disk degenerative disorder, lumbar spinal stenosis | Bursa City Hospital | Completed | No outcome recorded |
| — | NCT04718116 Comparator | Nov 2022 → Dec 2024 | chronic pain syndrome, neuropathy, painful | Aretaieion University Hospital | Unknown | No outcome recorded |
| — | NCT07394491 Comparator | Nov 2022 → Feb 2023 | — | Federal Teaching Hospital Abakaliki | Completed | No outcome recorded |
| — | NCT05566561 Comparator | Oct 2022 → Aug 2025 | disease of bone structure, osteoarthritis, knee | Medipol University | Completed | No outcome recorded |
| — | NCT05943015 Comparator | Sep 2022 → Dec 2024 | — | Gaziosmanpasa Research and Education Hospital | Completed | No outcome recorded |
| — | NCT05476510 Comparator | Aug 2022 → Jul 2023 | — | Medipol University | Completed | No outcome recorded |
| — | NCT05507554 Comparator | Aug → Oct 2022 | ureterolithiasis | Pakistan Kidney and Liver Institute and Research Center | Unknown | No outcome recorded |
| — | NCT05474014 Comparator | Jul 2022 → Nov 2023 | — | Bursa Yuksek Ihtisas Training and Research Hospital | Completed | No outcome recorded |
| — | NCT05401916 Comparator | Jun 2022 → Mar 2023 | — | Bezmialem Vakif University | Completed | No outcome recorded |
| — | NCT05693454 Comparator | Nov 2021 → Jan 2023 | vertebral column disorder | Balgrist University Hospital | Completed | No outcome recorded |
| — | NCT04809532 Background | Feb → Apr 2021 | — | Armed Forces Hospital, Pakistan | Unknown | No outcome recorded |
| — | NCT05696886 Comparator | Jan 2021 → Dec 2022 | — | Mansoura University | Completed | No outcome recorded |
| — | NCT04611685 Comparator | Oct 2020 → Oct 2021 | pituitary gland adenoma | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| — | NCT04443556 Comparator | Aug 2020 → Jan 2021 | — | Konya Meram State Hospital | Completed | No outcome recorded |
| — | NCT04814745 Comparator | Jul 2020 → Jan 2021 | — | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Completed | No outcome recorded |
| — | NCT04961268 Comparator | Jun 2020 → Feb 2021 | pulpitis | Alfarabi Colleges | Completed | No outcome recorded |
| — | NCT04294537 Background | Mar → Apr 2020 | appendicitis | Ospedale di Circolo - Fondazione Macchi | Unknown | No outcome recorded |
| — | NCT04314050 Comparator | Mar → Jun 2020 | — | Ankara Diskapi Training and Research Hospital | Completed | No outcome recorded |
| — | NCT04189640 Comparator | Jan 2020 → Jun 2022 | chronic pain syndrome, osteoarthritis, knee | Medipol University | Withdrawn | No outcome recorded |
| — | NCT04172272 Comparator | Sep 2019 → Sep 2020 | chronic pain syndrome, endometriosis, leiomyoma, pelvic organ prolapse +1 | General Hospital Pula | Unknown | No outcome recorded |
| — | NCT04058444 Background | Sep 2019 → Mar 2020 | — | Pujic Borislava | Unknown | No outcome recorded |
| — | NCT03719157 Comparator | Apr → Sep 2019 | — | Diskapi Yildirim Beyazit Education and Research Hospital | Completed | No outcome recorded |
| — | NCT03902340 Comparator | Dec 2018 → Jun 2019 | osteoarthritis, knee | Sublimed | Unknown | No outcome recorded |
| — | NCT03543202 Background | Jun 2018 → May 2019 | biliary tract disorder | Diskapi Yildirim Beyazit Education and Research Hospital | Completed | No outcome recorded |
| — | NCT03494426 Background | Apr 2018 → Jan 2020 | chronic pain syndrome | Assiut University | Completed | No outcome recorded |
| — | NCT04761029 Comparator | Jan 2018 → Jul 2020 | gallbladder disorder | Bursa Yuksek Ihtisas Training and Research Hospital | Completed | No outcome recorded |
| — | NCT04003350 Background | Dec 2017 → Nov 2018 | osteoarthritis, knee | Rothman Institute Orthopaedics | Completed | No outcome recorded |
| — | NCT03308955 Comparator | Aug 2017 | gallbladder disorder | Bursa Yuksek Ihtisas Training and Research Hospital | Completed | No outcome recorded |
| — | NCT03653520 Comparator | Jun → Nov 2017 | cataract | Avanti Anesthesia | Completed | No outcome recorded |
| — | NCT03358888 Comparator | Jun 2017 → Jan 2018 | osteoarthritis, hip | Rothman Institute Orthopaedics | Completed | No outcome recorded |
| — | NCT02824770 Background | Jan → Jun 2017 | — | Eskisehir Osmangazi University | Unknown | No outcome recorded |
| — | NCT03785041 Comparator | Dec 2016 → Dec 2017 | — | Ain Shams University | Completed | No outcome recorded |
| — | NCT02883569 Background | Sep 2016 → Dec 2020 | — | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT03277599 Comparator | Jul → Dec 2016 | — | Bursa Yuksek Ihtisas Training and Research Hospital | Completed | No outcome recorded |
| — | NCT03217292 Background | Jul → Dec 2016 | peripheral nerve lesion | Bursa Yuksek Ihtisas Training and Research Hospital | Completed | No outcome recorded |
| — | NCT04209478 Background | May → Nov 2016 | neuropathy, painful | Bakirkoy Dr. Dr. Sadi Konuk Research and Training Hospital | Completed | No outcome recorded |
| — | NCT03204708 Comparator | Apr 2016 → Feb 2017 | breast cancer | Istanbul University | Completed | No outcome recorded |
| — | NCT02914028 Comparator | Apr → Aug 2016 | — | Istanbul University | Completed | No outcome recorded |
| — | NCT02683070 Comparator | Mar 2016 → Feb 2018 | — | West China Hospital | Unknown | No outcome recorded |
| — | NCT03243006 Comparator | Jan → Sep 2016 | — | University of Monastir | Completed | No outcome recorded |
| — | NCT02674737 Comparator | Jan → May 2016 | postgastrectomy syndrome | Chinese Medical Association | Unknown | No outcome recorded |
| — | NCT02670954 Background | Oct → Dec 2015 | — | Chinese Medical Association | Completed | No outcome recorded |
| — | NCT02384928 Comparator | Sep 2015 → Jan 2017 | lumbar disk disease, sciatica | Jaseng Medical Foundation | Completed | No outcome recorded |
| — | NCT02497326 Background | Apr → Dec 2015 | — | King Edward Medical University | Unknown | No outcome recorded |
| — | NCT02375100 Background | Feb → Oct 2015 | neuropathy, painful | Bozyaka Training and Research Hospital | Completed | No outcome recorded |
| — | NCT02355678 Background | Jan → Aug 2015 | — | Makassed General Hospital | Completed | No outcome recorded |
| — | NCT02132416 Comparator | May 2014 → Jun 2017 | — | Sahlgrenska University Hospital | Completed | No outcome recorded |
| — | NCT02094807 Background | Apr 2014 → May 2020 | — | Sahlgrenska University Hospital | Withdrawn | No outcome recorded |
| — | NCT03482492 Comparator | Mar 2014 → Jan 2015 | lumbar disk disease | Yeditepe University Hospital | Completed | No outcome recorded |
| — | NCT01943435 Comparator | Nov 2013 → Jun 2016 | lumbar spinal stenosis | Michael Schneider, DC, PhD | Completed | No outcome recorded |
| — | NCT02625506 Comparator | Jun 2012 → Dec 2015 | breast cancer | Mansoura University | Completed | No outcome recorded |
| — | NCT01636700 Comparator | Oct 2011 → Jul 2014 | — | Federal University of São Paulo | Withdrawn | No outcome recorded |
| — | NCT02499341 Comparator | Jul 2011 → Jul 2014 | — | Attikon Hospital | Completed | No outcome recorded |
| — | NCT01263652 Comparator | Dec 2010 → Jun 2019 | — | Western Galilee Hospital-Nahariya | Withdrawn | No outcome recorded |
| — | NCT01024348 Comparator | Dec 2009 → Dec 2010 | — | Shaare Zedek Medical Center | Unknown | No outcome recorded |
| — | NCT00981929 Comparator | Sep → Dec 2009 | — | University of Southern Denmark | Terminated | No outcome recorded |
| — | NCT01165814 Comparator | Aug 2006 → Mar 2009 | — | Bnai Zion Medical Center | Completed | No outcome recorded |
Press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2002-06-20 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Announces Approval of Tramadol HCl Tablets tevapharm.com ↗ |
| 2002-01-17 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Announces Approvable Status of ANDA for Tramadol HCl Tablets tevapharm.com ↗ |
Evidence & citations 47 cited values
Every value below carries the sentence it was read from. 404 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tramadol | “The purpose of this study is to compare the pharmacokinetic (PK) of single oral doses of ULTRAM Extended Release (ER) at 2 dose levels in adolescents between 12 and 17 years...” NCT01586507 ↗359“Eligible patients were randomized (1:1) to receive low-dose 7-day BTDS (5, 10, and 20 μg/h, maximum dosage of 20 μg/h) or sustained-release tramadol tablets (100 mg, maximum...” PMID 25503600 ↗ Jul 2015 “All patients will be submitted to the institution's standard management: multimodal analgesia with common analgesic (dipyrone 4 to 8 g / day or paracetamol 1500 to 2250 mg /...” NCT07666178 ↗ “400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; PCA (patient-controlled analgesia): 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval,...” NCT05474014 ↗ “Purpose: pharmacokinetic interactions and safety of AD-2111 and AD-2112 in healthy adult volunteers Condition or disease : Pain Intervention/treatment Drug : AD-2111(Celecoxib...” NCT04375865 ↗ “Afterward of the operation, patients will be treated with patient-controlled analgesia with intravenous tramadol, with 20 mg bolus 20 minutes lock time, 4-hour limit 100 mg and...” NCT05943015 ↗ “initially receiving nefopam and tramadol, implementing with ketamine if patients remain painful, and then implementing with remifentanil with escalating doses in case of...” PMID 39832962 ↗ Jan 2025 “A patient controlled device prepared with 5 mg/ ml tramadol will be attached to all patients with a protocol included 10 mg bolus without infusion dose, 20 min lockout time and...” NCT05630404 ↗ “Nonsteroidal anti-inflammatory drug celecoxib (200 mg on request, up to two times daily)27 and tramadol (100 mg on request, up to 400mg daily) will be available for as-needed analgesia.” NCT06344403 ↗ “Both groups will receive intravenous 400 mg ibuprofen and 100 mg tramadol 20 minutes before the end of the surgery, and routine 1000 mg paracetamol every 8 hours postoperatively” NCT07534488 ↗ “Intravenous paracetamol 1 gr and a dose of 0,5 mg/kg-1 tramadol intravenously will be performed on all patients 30 min before the end of the surgery for postoperative analgesia.” NCT05621161 ↗ “Tramadol at a concentration of 5 mg/mL is included in our PCA protocol (total volume 100 mL.) PCAs were set to no basal infusion and 10 mg bolus doses with a 20 min lock time.” NCT03719157 ↗ “Morphine 5 mg, ropivacaine 150 mg, tramadol 40 mg, epinephrine 1 mg, ketorolac 60 mg, and ketamine 1 g will be mixed with normal saline to prepare a total volume of 60 ml” NCT06113497 ↗ “Tramadol is prescribed but the prescription is printed and given to the patient rather than sent to the pharmacy, requiring the patient to actively choose to fill it.” NCT07672808 ↗ “Tramadol immediate release formulation (IR, one intake every 6 hours) or prolonged release formulation (PR, one intake every 12 hours); maximum posology 400mg/24h.” NCT03902340 ↗ “DW-1021 is a fixed-dose combination tablet containing Pelubiprofen 45 mg and Tramadol 45.9 mg (as a salt), formulated as a controlled-release film-coated tablet.” NCT07032558 ↗ “(n=30) will receive a submucosal infiltration with 2 mg kg-1 tramadol in 3 mL of normal saline (1.5 ml around each tonsil), 3 minutes before surgical incision.” NCT01552096 ↗ “When the NRS score was ≥4, flurbiprofen axetil 50 mg was administered intravenously, with intramuscular tramadol 100 mg added if analgesia was inadequate.” NCT07315022 ↗ “The regimen includes Paracetamol (oral or intravenous) 1g/24 hour, Ibuprofen IV 1200 mg/24 hour, or Parecoxib 80 mg/24 hour IV, and Tramadol 100 mg IV.” NCT07139691 ↗ “continuous wound inflitration with ropivacaine + tramadol patient-controlled analgesia + additional ketorolac or propacetamol for postoperative 48 hour” NCT02012244 ↗ “Cytochrome P450 2D6 (CYP2D6) is an important enzyme in metabolizing commonly used drugs such as Tramadol hydrochloride (widely used opioid analgesic).” NCT06642480 ↗ “All patients will receive rescue analgesia with intravenous patient controlled analgesia with tramadol (20 mg bolus dose and 20 minutes lockout time)” NCT03543202 ↗ “Routine prescriptions for rescue opioids (tramadol) and NSAIDs according to pain level recommended by the pharmacy department will be administered.” NCT06015165 ↗ “An extended-release (ER) fixed-dose combination (FDC) of tramadol 37.5 mg/acetaminophen 325 mg was developed due to the demand for varying dosages.” PMID 35800670 ↗ Jun 2022 “Intravenous 0.5 mg/kg tramadol and 400 mg ibuprofen will be administered to all patients 30 minutes before the end of the surgical procedure.” NCT05566561 ↗ “Ultracet (tramadol/acetaminophen) 37.5/325 mg/mg capsules twice daily on Day 1, a first dose at t = 0 hrs, and a second dose at t = 12 hrs.” NCT00772967 ↗ “Tramadol 37.5 mg/APAP 325 mg combination tablets (Ultracet®) one tablet twice a day plus aceclofenac tablet per oral 100 mg twice a day.” NCT00647517 ↗ “All patients were followed using a standardized postoperative analgesia protocol which includes tramadol patient controlled analgesia.” NCT06326281 ↗ “A Pharmacokinetic Study to Evaluate the Dose-Proportionality of Tramadol (ULTRAM) Extended-Release (ER) in Healthy Participants” NCT01800682 ↗ “A fixed-dose combination controlled release film-coated tablet containing pelubiprofen 45 mg and tramadol 45.9 mg (salt form)” NCT07060209 ↗ “In the preemptive tramadol (n = 158) group, patients received an iv injection of tramadol 100 mg 15 min before operation.” PMID 18622068 ↗ May 2008 “Continous postoperative infusion of tramadol 300 mg and metamizole 2,5 g (in 500 ml 0.9% NaCl, rate of infusion 40 ml/h)” NCT05831761 ↗ “100 mg of tramadol hydrochloride was placed in 150 cc isotonic saline and given as a 15-minute intravenous infusion.” NCT05500677 ↗ “Drug: intravenous injection Tramadol 50 mg and then oral capsule Tramadol 50 mg, once patient starts taking orally.” NCT05507554 ↗ “Patients in Group A received injection tramadol 50mg intravenously every 8 hours following surgery.” NCT06608056 ↗ “tramadol 50 mg intravenously up to a maximum dose of 400 mg / 24 h and other analgesics if needed.” NCT04172272 ↗ “Tramadol 100 mg in the first hour followed by tramadol 300 mg continuously for the next 24 hours.” NCT04587505 ↗ “Tramadol 100 mg in the first hour followed by tramadol 300 mg continuously for the next 24 hours.” NCT04521556 ↗ “Tramadol is a synthetic opioid pain medication used to treat moderate to moderately severe pain.” NCT04813016 ↗ “medications in the opioid family such as Hydromorphone, Hydrocodone, Tramadol, or Oxycodone.” NCT04176783 ↗ “rescue analgesia with tramadol 37,5 mg + acetaminophen 325 mg oral fix combination (Patrol)” NCT02035904 ↗ “and intravenous opioids (buprenorphine 3 mcg / kg or tramadol 1mg/ kg in continuos infusion” NCT02617199 ↗ “patients in iv analgesia group were given 100 mg tramadol iv 30 minutes before extubation.” NCT03204708 ↗ “Drug: Tramadol 400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline” NCT07096765 ↗ “This includes tylenol 650 mg oral, robaxin 500 mg oral, and tramadol 25-50 mg oral.” NCT05144828 ↗ “Drug: Tramadol Women will receive oral Tramadol 100 mg 2 hours before the procedure” NCT03585036 ↗ “Multi-modal with as needed oxycodone and tramadol provided for break-through pain” NCT03358888 ↗ “In case of severe pain tramadol 0,5 mg/kg will be administered iv every 8 hours.” NCT04294537 ↗ “9. 10 tablets of Tramadol 50mg as needed for moderate breakthrough pain only.” NCT06561035 ↗ “Tramadol 100mg (For pain, the patient may take a rescue medication as needed)” NCT07568938 ↗ “Tramadol is a unique opioid with two modes of action for inhibition of pain” NCT04551833 ↗ “Patient will receive intravenous patient controlled analgesia with tramadol” NCT04457986 ↗ “If the VAS score will be ≥ 4, 0.5 mg/ kg tramadol IV will be administered.” NCT04189640 ↗ “2 capsules of Ixprim® given orally (1000 mg Paracetamol + 75 mg Tramadol)” NCT01782846 ↗ “TAB. Zaldiar (Paracetamol 650 milligrams + Tramadol 75 milligrams).” NCT01764048 ↗ “Regular Tramadol, Metamizol, +/- Ibuprofen/Dexketorpofen/Parecoxib” NCT07604376 ↗ “Tramadol 100 mg if Weight over 50 kg, 50 mg if weight below 50 kg” NCT01345162 ↗ “the PK parameter AUC∞ (area under the curve) of racemic tramadol.” NCT01586494 ↗ “Aceclofenac 100mg or tramadol37.5mg/acetaminophen 325mg on demand” NCT01952314 ↗ “Celebrex 400mg PO, Lyrica 75mg x1 dose pre-op, Tramadol 50mg x 1” NCT06113211 ↗ “Adjunctive analgesics: acetaminophen, tramadol, or gabapentin” NCT01943435 ↗ “Tramadol 2mg/Kg IV in 100mL of normal saline, if pain NRS\>3.” NCT03534895 ↗ “immediate-release tramadol 100 mg four times daily (QID)” PMID 35974668 ↗ Sep 2022 “100 mg tramadol will be performed for rescue analgesia.” NCT05476510 ↗ “Tramadol 50 mg BID or TID and titrate to 100 mg QID” NCT00386243 ↗ “Morphine, oxycodone, metadone, fentanyl, tramadol” NCT03365817 ↗ “with tramadol and/or morphine provided as rescue.” NCT07337135 ↗ “tramadol hydrochloride (Drug class: Opioids)” NCT02384928 ↗ “YYC301-1: Tramadol 37.5Mg+ Celecoxib 200mg” NCT05362851 ↗ “Tramadol 50 mg every 6 hours prn for pain” NCT03640247 ↗ “Rescue therapy only: Tramadol 50-100mg.” NCT04894864 ↗ “50 mg tramadol IV if pain persisted” NCT07057934 ↗ “Rescue therapy only: Tramadol” NCT05172739 ↗ “with 100 mg tramadol as PE” NCT03785041 ↗ “tramadol administration” NCT04814745 ↗ “Level 2: Tramadol 50mg.” NCT04330547 ↗ “tramadol/acetominophen” NCT02361567 ↗ “Tramadol 50mg IV q6h” NCT04058444 ↗ “Tramadol (Ultram®)” NCT06240390 ↗ “Tramadol 100 mg” NCT05657704 ↗ “Tramadol 50mg” NCT06495632 ↗ “Tramadol” NCT02094807 ↗ “Tramadol” NCT02132416 ↗ “tramadol” NCT05463367 ↗ |
| Known as | AD-2112 | “Purpose: pharmacokinetic interactions and safety of AD-2111 and AD-2112 in healthy adult volunteers Condition or disease : Pain Intervention/treatment Drug : AD-2111(Celecoxib...” NCT04375865 ↗ |
| Known as | contramal | “patients were given intravenously 100 mg of tramadol (contramal) 30 minutes before extubation after modified radical mastectomy.” NCT03204708 ↗ |
| Known as | ETS6103 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02014363 ↗ |
| Known as | Extended Release Tramadol | “Extended Release Tramadol (Tramadol ER)” NCT00347724 ↗ |
| Known as | TA-ER | “OBJECTIVE: To evaluate the relative efficacy and safety of extended-release tramadol HCl 75 mg/acetaminophen 650 mg (TA-ER) and immediate-release tramadol HCl...” PMID 25299350 ↗ Oct 2014 |
| Known as | TA-IR | “OBJECTIVE: To evaluate the relative efficacy and safety of extended-release tramadol HCl 75 mg/acetaminophen 650 mg (TA-ER) and immediate-release tramadol HCl...” PMID 25299350 ↗ Oct 2014 |
| Known as | Tradonal Odis | “Tramadol per os (Tradonal Odis® orodispersible tablets)” NCT00735748 ↗ |
| Known as | TRAM | “Since JNS013 is a combination of tramadol hydrochloride (TRAM) acting as a weak opioid with acetaminophen (APAP) inhibiting central COX-3” NCT00752661 ↗2“fixed combination of dexketoprofen trometamol (DKP) and tramadol hydrochloride (TRAM)” NCT01902134 ↗ “tramadol hydrochloride (TRAM)” NCT00736957 ↗ |
| Known as | Tram (Tradol) | “Tram (Tradol®)” NCT05389150 ↗ |
| Known as | Trama | “Women will receive Tramadol 100mg (Trama®, Global Napi, Giza, Egypt) orally 2 hours before IUD insertion.” NCT02827487 ↗2“Tramadol 100mg (Trama®, Global Napi, Giza, Egypt) orally in addition to a placebo similar to Celecoxib” NCT02736019 ↗ “Tramadol 100mg (Trama®, Global Napi, Giza, Egypt) orally” NCT03585036 ↗ |
| Known as | Trama SR | “Group I who will receive Tramadol 100mg (Trama SR®, Global Napi) orally 1 hour before the procedure, group II who will receive Celecoxib 200mg (Celebrex® 200, Pfizer) 1 hour...” NCT02071303 ↗1“Group I who will receive Tramadol 100mg (Trama SR®, Global Napi) orally 1 hour before the procedure” NCT02419651 ↗ |
| Known as | Tramadol 100 MG/ML | “Tramadol 100 MG/ML” NCT03785041 ↗ |
| Known as | Tramadol 50 MG/ML | “Tramadol 50 MG/ML” NCT03785041 ↗ |
| Known as | Tramadol BID | “A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol OAD Tablets to Twice Daily Tramadol BID for the Treatment of Osteoarthritis of the Knee (Extension...” NCT00912015 ↗ |
| Known as | Tramadol Contramid OAD | “A three-way crossover study in 27 human volunteers was conducted to characterize
the pharmacokinetics and to assess the dose proportionality of 100 mg, 200 mg
and 300 mg...” PMID 17575561 ↗ Sep 20075“CONCLUSIONS: The results of this exploratory study suggest that similar to immediate-release tramadol, onset of analgesia for this controlled-release formulation of tramadol...” PMID 19070266 ↗ Sep 2008 “This placebo-controlled study examined the analgesic efficacy, safety, and clinical benefit of Tramadol Contramid OAD, a once-daily formulation with both immediate- and...” PMID 18181382 ↗ Sep 2007 “An open-label phase was followed by a double-blind phase, in which a total of 646 patients were randomized to double-blind treatment with placebo or Tramadol Contramid OAD.” PMID 17583466 ↗ Jun 2007 “two Tramadol Contramid® OAD 300 mg controlled-release tablets from two different manufacturing sites” NCT00834912 ↗ “once-daily formulation of tramadol (Tramadol Contramid OAD 200-mg tablets)” PMID 20051587 ↗ Jan 2010 |
| Known as | Tramadol Contramid once-a-day | “The primary objective of this study is to determine the time of onset of analgesic effect of Tramadol Contramid® Once-A-Day (OAD) in acute low back pain.” NCT00952068 ↗ |
| Known as | Tramadol Contramid once-daily | “The aim of this study was to compare the pharmacokinetic profile and oral bioavailability of Tramadol Contramid once-daily (o.d.) 200 mg tablets (Labopharm, Canada) with that...” PMID 16894407 ↗ Jul 2006 |
| Known as | tramadol ER | “A 7-day taper using clonidine (n = 36), tramadol ER (n = 36), or buprenorphine (n = 31) was then instituted, and patients were crossed-over to double-blind placebo during a...” PMID 28700791 ↗ Sep 20172“Open-label Assessment of the Safety and Effectiveness of Extended Release Tramadol (Tramadol ER) in the Treatment of Chronic Non-malignant Pain.” NCT00347685 ↗ “Extended Release Tramadol (Tramadol ER)” NCT00347724 ↗ |
| Known as | Tramadol HC1 IR | “Some participants will receive a medication approved by the Food and Drug Administration for treatment of moderate to moderately severe pain called Tramadol HC1 IR.” NCT01598753 ↗ |
| Known as | Tramadol HCl | “Participants will receive 1 tablet containing 75 mg of tramadol HCl and 650 mg of acetaminophen, once daily on Days 1to 3, then 1 tablet twice daily on Days 4 to 7” NCT01112267 ↗15“The reference treatment consists of two separate controlled-release film-coated tablets: Pelubi CR (Pelubiprofen 45 mg) and Zytram CR (Tramadol HCl 75 mg).” NCT07032558 ↗ “Cases were assessed as intravenous opioid with 1 mg/kg tramadol HCl (Group O, n=20) or ultrasonography-guided quadratus lumborum block (Group B, n=20).” NCT03693222 ↗ “A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol HCl Once-a-Day Versus Placebo for the Treatment of Pain Due to Osteoarthritis” NCT00833794 ↗ “the test product, Tramadol HCl Once-A-Day (OAD) 200 mg tablets and the reference product, Tramadol HCl 50 mg (IR) tablets (Ortho-McNeil Ultram®).” NCT00834288 ↗ “Patients will be equally assigned to receive a total dose of either tramadol HCl 75 mg/acetaminophen 650 mg or tramadol HCl 100 mg or placebo.” NCT00236483 ↗ “Patients will receive infusion of Tramadol HCl (Tramosel®) via patient-controlled analgesia system (Gemstar®)” NCT02824770 ↗ “Tramadol HCL. Dosage form: Injection Strength: 50mg/ampoule Frequency: 1 time” NCT01887951 ↗ “DDS-06C (650 mg acetaminophen and 75 mg tramadol HCl)” NCT00973232 ↗ “Group II:received IV 2 mg/kg tramadol HCL.” NCT02449954 ↗ “Tramadol HCl, 50 mg” NCT01947920 ↗ “Drug: Tramadol HCl” NCT00834912 ↗ “Drug: tramadol HCL” NCT00662558 ↗ |
| Known as | Tramadol HCl ER | “The purpose of this study is to compare the analgesic efficacy and safety of tramadol HCl ER 100 mg, 200 mg and 300 mg once a day (QD), with placebo in patients with moderate...” NCT00348452 ↗2“Extended-release Tramadol Hydrochloride(Tramadol HCl ER)100 Mg, 200 Mg, 300 Mg, And 400 Mg With Placebo” NCT00325858 ↗ “Extended Release Tramadol Hydrochloride (Tramadol HCl ER)” NCT00348010 ↗ |
| Known as | Tramadol HCl ODT | “The purpose of this clinical trial is to test an experimental drug therapy called Tramadol Hydrochloride (HCl) Orally Disintegrating Tablets (ODT) ("Tramadol HCl ODT" or the...” NCT00983736 ↗1“The purpose of this clinical trial is to test an experimental drug therapy called Tramadol Hydrochloride (HCl) Orally Disintegrating Tablets (ODT) ("Tramadol HCl ODT" or the...” NCT00983151 ↗ |
| Known as | Tramadol HCl/Acetaminophen ER | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01814878 ↗ |
| Known as | Tramadol HCl/Acetaminophen IR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01814878 ↗ |
| Known as | Tramadol Hydrochloride | “Tramadol hydrochloride, a synthetic opioid is an orally active, clinically effective centrally acting analgesic having a lower incidence of respiratory depression, cardiac...” NCT02071303 ↗49“A Randomized, Double-blind, Multi-site, Comparator-controlled, Phase III Trial to Evaluate the Efficacy and Safety of a Fixed-dose Combination of Tramadol Hydrochloride and...” NCT03714672 ↗ “The combination of tramadol hydrochloride and acetaminophen in an extended-release formulation has been shown to provide rapid and long-lasting analgesic effects resulting from...” PMID 24183364 ↗ Oct 2013 “A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Two Doses of Tramadol Hydrochloride Orally Disintegrating Tablets in...” NCT00983736 ↗ “The purpose of this clinical trial is to test an experimental drug therapy called Tramadol Hydrochloride (HCl) Orally Disintegrating Tablets (ODT) ("Tramadol HCl ODT" or the...” NCT00983151 ↗ “Tramadol hydrochloride, a centrally acting, synthetic analgesic, has been available in Europe since 1977 in a variety of formulations and in the United States since 1995.” PMID 19070266 ↗ Sep 2008 “Extended Release Tramadol Hydrochloride (Tramadol HCl ER) 100 mg, 200 mg, 300 mg, Celecoxib 200 mg and Placebo in the Treatment of Osteoarthritis of the Knee and/or Hip.” NCT00348452 ↗ “DW-1021 is a novel fixed-dose combination salt formulation containing pelubiprofen 45 mg and tramadol hydrochloride 45.9 mg (equivalent to 40.3 mg tramadol free base).” PMID 41821212 ↗ Mar 2026 “Tramadol hydrochloride is a synthetic analog of codeine that acts on both opioid (weak m receptor agonist) and nonopioid receptors” NCT04391855 ↗ “Intravenous Tramadol hydrochloride 100 milligrams + TAB. Paracetamol 500 milligrams + TAB. Diclofenac 100 milligrams” NCT01764048 ↗ “Tramadol hydrochloride, a synthetic opioid is an orally active, clinically effective centrally acting analgesic” NCT02419651 ↗ “Tramadol hydrochloride, a synthetic opioid is an orally active, clinically effective centrally acting analgesic” NCT02428777 ↗ “Extended-release Tramadol Hydrochloride(Tramadol HCl ER)100 Mg, 200 Mg, 300 Mg, And 400 Mg With Placebo” NCT00325858 ↗ “fixed combination of dexketoprofen trometamol (DKP) and tramadol hydrochloride (TRAM)” NCT01902134 ↗ “Patients are receiving tramadol hydrochloride under thoracic surgery” NCT06172920 ↗ “Extended Release Tramadol Hydrochloride (Tramadol HCl ER)” NCT00348010 ↗ “tramadol hydrochloride (Drug class: Opioids)” NCT02384928 ↗ “Tramadol Hydrochloride SR Tablets” NCT06780267 ↗ “Tramadol Hydrochloride 10 mg i.v.” NCT00519246 ↗ “Tramadol hydrochloride injection” NCT05390905 ↗ “Drug: Tramadol Hydrochloride” NCT07440069 ↗ “Drug: Tramadol Hydrochloride” NCT00510666 ↗ “Drug: Tramadol Hydrochloride” NCT03694873 ↗ “Drug: Tramadol Hydrochloride” NCT02999594 ↗ “Tramadol Hydrochloride 50mg” NCT00290901 ↗ |
| Known as | tramadol hydrochloride (HCl) | “The purpose of this study is to determine the safety and tolerability profile of tramadol hydrochloride (HCl) given as oral doses every 6 hours, within the range of dosages...” NCT01947920 ↗1“1x300mg Tramadol Hydrochloride (HCl) tablet (Confab Laboratories), fasting condition.” NCT00834912 ↗ |
| Known as | tramadol hydrochloride extended-release (ER) | “OBJECTIVE: To evaluate whether tramadol hydrochloride extended-release (ER), an approved analgesic with opioid and nonopioid mechanisms of action and low abuse potential, is...” PMID 28700791 ↗ Sep 2017 |
| Known as | Tramadol OAD | “A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol OAD Tablets to Twice Daily Tramadol BID for the Treatment of Osteoarthritis of the Knee (Extension...” NCT00912015 ↗1“The purpose of this study is to compare the analgesic efficacy, safety and clinical benefit of Tramadol OAD tablets versus Placebo.” NCT00833794 ↗ |
| Known as | tramadol ODT | “Subjects were randomized to receive 1:1:1 placebo (n=200), 62 mg tramadol ODT (n=206), or 89 mg tramadol ODT (n=198).” PMID 21889833 ↗ Aug 2011 |
| Known as | Tramadol Once a day | “One Tramadol Once A Day tablet at randomized dose daily.” NCT00832416 ↗1“Drug: Tramadol Once a day” NCT00833794 ↗ |
| Known as | Tramadol Once-A-Day (OAD) | “The purpose of this study is to evaluate the long-term safety (up to one year) of Tramadol Once-A-Day (OAD) tablets at the highest doses: 200-400 mg” NCT00912015 ↗ |
| Known as | tramadol retard actavis | “The subjects will orally ingest 100 mg tramadol retard actavis” NCT03934411 ↗ |
| Known as | Tramadolhydrochlorid | “Tapentadol (Palexia Depot), and Tramadolhydrochlorid (Mandolgin Retard)” NCT03121547 ↗ |
| Known as | Tramal | “Patients in group Tramadol will intravenously administrate dose of 1 mg/kg/8hr tramal to be increased upon patient needs up to 2mg/kg/6hr as rescue analgesic” NCT04613830 ↗6“an oral tramadol tablet (Tramal®, Memphis, Giza, Egypt) 1 h before the procedure” NCT03701984 ↗ “The control group routinely injected tramadol 100mg(Tramal) intramuscularly” NCT07066111 ↗ “Tramadol 50mg (Tramal ®, Memphis,) orally 1 hour before the procedure” NCT02425709 ↗ “an oral tramadol 50 mg(Tramal, Memphis, Giza, Egypt) tablet” NCT03532841 ↗ “Drug: Tramal®” NCT04647435 ↗ |
| Known as | Tramal drops | “Tramadol hydrochloride (Tramal drops, Laboratoire, Grunenthal, Aachen-Germany) would be given.” NCT02355678 ↗ |
| Known as | Tramal retard | “Initial dose of oral tramadol (depottabl Tramal retard, Orionpharma, Finland) will be 100mg once daily.” NCT01116531 ↗ |
| Known as | Tramaw | “one tablet of Tramadol 100 mg (Tramaw, Global Napi, Giza,Egypt) administered orally immediately, 12 h and 24 h after randomization.” NCT03694873 ↗ |
| Known as | Tramosel | “Patients will receive infusion of Tramadol HCl (Tramosel®) via patient-controlled analgesia system (Gemstar®)” NCT02824770 ↗ |
| Known as | Tridol SR | “tramadol (Tridol® SR (slow release) Tablet 100mg)” NCT01019265 ↗ |
| Known as | Tridol SR tab | “TramadolSR tab (Tridol SR tab)” NCT01019265 ↗ |
| Known as | Ultram | “The purpose of this study is to compare the safety, pharmacokinetic properties (the absorption, distribution and excretion), and analgesic activity of Omnitram (10 mg tablets),...” NCT02205554 ↗5“This study investigates if Celebrex is as effective as tramadol hydrochloride (Ultram) for patients with chronic low back pain, when administered over a 6-week period.” NCT00290901 ↗ “the test product, Tramadol HCl Once-A-Day (OAD) 200 mg tablets and the reference product, Tramadol HCl 50 mg (IR) tablets (Ortho-McNeil Ultram®).” NCT00834288 ↗ “IV Tramadol \[Ultram\] introduced when needed after surgery” NCT06112548 ↗ “50 mg tramadol (1x50 mg Ultram tablet)” NCT03312777 ↗ “Tramadol (Ultram®)” NCT06240390 ↗ |
| Known as | Zertane | “To assess the safety of tramadol orally disintegrating tablet (ODT) (Zertane) and its efficacy in prolonging intravaginal ejaculation latency time (IELT) and improving...” PMID 21889833 ↗ Aug 2011 |
| Known as | Zytram CR | “The reference treatment consists of two separate controlled-release film-coated tablets: Pelubi CR (Pelubiprofen 45 mg) and Zytram CR (Tramadol HCl 75 mg).” NCT07032558 ↗ |
| Action | Inhibit | “Its mechanism of action involves weak binding to the mu-opioid receptors and inhibition of reuptake of both norepinephrine and serotonin.” PMID 18052769 ↗ Dec 2007 |
| Modality | Small molecule | “centrally acting opioid pain killer” NCT01558622 ↗ |
| Route | Oral | “oral tramadol” NCT00111046 ↗ |